Combination of Janus kinase inhibitor and biologic for recalcitrant severe atopic dermatitis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Combination of Janus kinase inhibitor and biologic for recalcitrant severe atopic dermatitis

Published:2024-05-29 Issue: Volume: Page:
ISSN:0926-9959
Container-title:Journal of the European Academy of Dermatology and Venereology
language:en
Short-container-title:Acad Dermatol Venereol

Author:

De Greef Axel¹²^ORCID,Baeck Marie¹²^ORCID

Affiliation:

1. Dermatology Department Cliniques universitaires Saint‐Luc, UCLouvain Brussels Belgium

2. Institute of Experimental and Clinical Research (IREC), Pneumology, ENT and Dermatology Pole (LUNS) Université catholique de Louvain (UCLouvain) Brussels Belgium

Funder

Fonds De La Recherche Scientifique - FNRS

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jdv.20132

Reference6 articles.

1. The New Era of Biologics in Atopic Dermatitis: A Review

2. Dupilumab with concomitant Janus kinase inhibitor: a novel treatment strategy for atopic dermatitis with poor response to dupilumab

3. Remission of severe atopic dermatitis with dupilumab and rescue tofacitinib therapy

4. JAK-inhibitors as rescue therapy in dupilumab-refractory severe atopic dermatitis: A case series of 6 patients

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP